July 2024 Insights Into Three SEHK Stocks Estimated As Undervalued

In This Article:

As global markets experience varying levels of performance, with notable shifts in indices like the Russell 2000 and S&P 500, investors are keenly watching for opportunities. The Hong Kong market, reflecting a blend of resilience and challenges amid these global trends, presents unique investment avenues in potentially undervalued stocks that could be poised for adjustment. In such an environment, discerning investors might find that stocks deemed undervalued according to fundamental analysis could represent compelling opportunities for portfolio diversification.

Top 10 Undervalued Stocks Based On Cash Flows In Hong Kong

Name

Current Price

Fair Value (Est)

Discount (Est)

China Resources Mixc Lifestyle Services (SEHK:1209)

HK$24.65

HK$47.49

48.1%

China Cinda Asset Management (SEHK:1359)

HK$0.68

HK$1.29

47.4%

Zhaojin Mining Industry (SEHK:1818)

HK$15.72

HK$30.33

48.2%

Zijin Mining Group (SEHK:2899)

HK$16.96

HK$32.26

47.4%

Super Hi International Holding (SEHK:9658)

HK$13.72

HK$25.78

46.8%

West China Cement (SEHK:2233)

HK$1.16

HK$2.15

46.2%

BYD (SEHK:1211)

HK$239.80

HK$462.54

48.2%

Mobvista (SEHK:1860)

HK$2.02

HK$3.72

45.7%

Vobile Group (SEHK:3738)

HK$1.26

HK$2.32

45.6%

Kingdee International Software Group (SEHK:268)

HK$6.35

HK$12.66

49.8%

Click here to see the full list of 41 stocks from our Undervalued SEHK Stocks Based On Cash Flows screener.

Let's take a closer look at a couple of our picks from the screened companies.

AK Medical Holdings

Overview: AK Medical Holdings Limited is an investment holding company that specializes in designing, developing, producing, and marketing orthopedic joint implants and related products both in China and internationally, with a market cap of approximately HK$5.26 billion.

Operations: The company generates revenue primarily through the sale of orthopedic implants, totaling CN¥993.59 million in China and CN¥152.49 million in the United Kingdom.

Estimated Discount To Fair Value: 41.2%

AK Medical Holdings is recognized for its robust growth prospects, with earnings expected to increase significantly over the next three years, outpacing the Hong Kong market's average. Currently trading at HK$4.69, the stock is considered undervalued by 41.2% against a fair value estimate of HK$7.98 based on discounted cash flow analysis. Despite a recent dividend decrease and board changes, its forecasted low Return on Equity of 13.7% in three years tempers enthusiasm slightly.